SBI Securities’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214 Sell
2
-9
-82% -$589 ﹤0.01% 3306
2026
Q1
$87 Sell
11
-3
-21% -$49 ﹤0.01% 3444
2025
Q4
$249 Sell
14
-9
-39% -$175 ﹤0.01% 3142
2025
Q3
$605 Buy
23
+2
+10% +$76 ﹤0.01% 2895
2025
Q2
$1.2K Buy
21
+3
+17% +$241 ﹤0.01% 2603
2025
Q1
$1.97K Buy
18
+2
+13% +$174 ﹤0.01% 2297
2024
Q4
$745 Buy
+16
New +$967 ﹤0.01% 2739

Other funds holding AGL

SBI Securities's AGL Position: Q2 2026 in Review

SBI Securities reduced its Agilon Health (AGL) stake by 82% in Q2 2026, selling an estimated $589 and leaving 2 shares worth $214. The position accounts for ﹤0.01% of the portfolio, ranked #3306.

SBI Securities first reported a position in AGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.97K in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • SBI Securities held 2 shares of Agilon Health worth $214 as of Q2 2026.
  • SBI Securities sold 9 Agilon Health shares in Q2 2026, an estimated $589.
  • Agilon Health made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3306 holding.
  • SBI Securities first reported a position in Agilon Health in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Agilon Health position peaked at $1.97K in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.